Breathe Well Live Well
|
Children Usually Excluded From Clinical Drug Trials: Study
MSN Health & Fitness In a new study, researchers looked at all clinical trials registered worldwide from 2006 to 2011 for drugs to treat these common conditions: asthma, migraine headaches, schizophrenia, depression, diarrheal illness, lower respiratory infection, malaria, … |
View full post on asthma – Google News
 World First Travel Insurance |
New drug to combat asthma symptoms
World First Travel Insurance A new drug has been found to significantly reduce asthma symptoms caused by common colds in the first week of infection. Treatment with SNG001 led to a 65% fall in the number of patients experiencing moderate worsening of symptoms, according to … |
View full post on asthma – Google News
|
Drug 'reduces asthma symptoms'
Nursing Times Half a million asthma sufferers in the UK could benefit from a “breakthrough” drug that reduces complications caused by the common cold, it was claimed today. You now need to register for FREE to read our news. Please sign in or register to continue … |
View full post on asthma – Google News
|
New drug can prevent exacerbations of asthma due to common cold: Trial report
News-Medical.net By Dr Ananya Mandal, MD For the tens of thousands of asthma sufferers in the UK there is a “breakthrough” drug that reduces complications caused by the common cold, it is claimed. Severe symptoms due to cold infections are one of the chief reasons why … Synairgen's 'breakthrough' asthma drug shines in Phase II trial Earlier trial with an unlicensed drug shows good relief in Asthma complications Scientists Hail Asthma Drug That 'Prevents Life-Threatening Symptoms' |
View full post on asthma – Google News
 Daily Mail |
New drug 'stops common cold asthma deaths'
Halifax Evening Courier The news is based solely on a press release, which gives some information about the findings of an early-stage clinical trial of a new, unlicensed asthma drug called SNG001. The press release describes research that was conducted in a total of 134 … Positive Results in Trial for New Asthma Treatment Positive SNG001 Phase II Asthma Clinical Trial Data Asthma drug 'protects sufferers from life-threatening symptoms caused by … |
View full post on asthma – Google News
Daily Mail |
New drug 'stops common cold asthma deaths'
Lutterworth Mail The news is based solely on a press release, which gives some information about the findings of an early-stage clinical trial of a new, unlicensed asthma drug called SNG001. The press release describes research that was conducted in a total of 134 … Positive Results in Trial for New Asthma Treatment Positive SNG001 Phase II Asthma Clinical Trial Data Asthma drug 'protects sufferers from life-threatening symptoms caused by … |
View full post on asthma – Google News
|
SkyePharma soars on asthma drug approval
Telegraph.co.uk By Rachel Cooper, City Reporter SkyePharma has been hurt by concerns over its asthma therapy, Flutiform, with the share price taking a tumble just before Christmas as traders learnt of another delay to its European approval. SkyePharma asthma drug wins European backing SkyePharma's asthma drug wins European backing |
View full post on asthma – Google News
|
SkyePharma asthma drug wins European backing
Reuters UK By Paul Sandle | LONDON (Reuters) – SkyePharma said on Friday its lead product, asthma therapy Flutiform, had been recommended for approval by European regulators, doubling the value of the group's shares. Flutiform was referred to the European … SkyePharma's asthma drug wins European backing |
View full post on asthma – Google News
|
SkyePharma's asthma drug wins European backing
Reuters UK LONDON (Reuters) – British pharmaceutical company SkyePharma said on Friday its asthma therapy Flutiform had been recommended for approval by European regulators, sending its shares soaring. Flutiform was referred to the European Medicines Agency (EMA) … |
View full post on asthma – Google News
Daily Mail |
Asthma drug 'protects sufferers from life-threatening symptoms caused by …
Daily Mail By Jenny Hope Scientists are developing a drug that will protect asthma sufferers from life-threatening symptoms caused by the common cold. A study shows an anti-viral agent known as SNG001 prevented two out of three asthmatics from getting worse after … Positive results trial for new asthma treatment Synairgen reports positive Phase II asthma trial data Synairgen no wheeze as asthma drug trial boosts shares |
View full post on asthma – Google News